Treatment in a recent study combined a histone deacetylase (HDAC) inhibitor - a drug that causes a chemical change to stop tumor cells from dividing - with two types of immunotherapy known as checkpoint inhibitors, which unharness the power of the immune response against cancer.
Read moreIn This Section
- Home
- Research & Innovation
- Stories with Impact
- College Team
- Programmes
- Hospital Partners
- Community Partners
- Jennings Gallery
- Graduate Studies
- Programmes for International (Non-EU) Students
- Interprofessional Learning (IPL)
- ASSERT
- Dr Ashleigh Byrne-O’Brien Memorial Fund & Awards
- iEd Hub
- Inaugural Professorial Lecture Series
- Learning, Teaching & Curriculum
- Philanthropic Lectures
- UCC Academic Health Sciences
- Continuing Professional Development
-
New three-drug combination treatment achieves notable responses in patients with advanced HER2-negative breast cancer
15 Feb 2024
-
UCC researchers find that people with COPD see improved health benefits from lifestyle changes
13 Feb 2024
- Research shows that people with the complex lung disease COPD see improved health benefits from behaviour change interventions.
- It is estimated that over 380,000 people in Ireland suffer from COPD.
- Interventions ‘has helped me greatly’ says woman with COPD.
-
Researchers develop new prediction tool to identify cognitive impairment
11 Jan 2024
Impaired cognition among preterm infants can be predicted prior to discharge from neonatal care, new joint Irish and Swedish research shows.
Read more
College of Medicine and Health Research & Innovation
Coláiste an Leighis agus na Sláinte Taighde agus Nuálaíocht
Contact us
3rd Floor, Erinville Hospital, Western Road, University College Cork, T12 EKDO